This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., Medical University of Lodz, The Brigham and Women's Hospital, Inc.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,268 
2 out of 2 
2 out of 1,428 
Years Active: 2022-2025
Title: Kevin M. Elias: Innovator in Ovarian Cancer Research
Introduction
Kevin M. Elias is an accomplished inventor based in Brookline, Massachusetts, renowned for his significant contributions to medical research, particularly in the field of ovarian cancer. With two patents to his name, Elias has focused his work on developing innovative methods and kits that enhance the detection and treatment of this critical health issue.
Latest Patents
Elias's most notable patents include innovative approaches for determining the presence of specific microRNA biomarkers associated with ovarian cancer. His patents provide methods and kits for detecting these biomarkers in blood samples from female patients. This groundbreaking work enables healthcare professionals to screen patients effectively for ovarian cancer and offers potential treatment methods for those diagnosed with the condition.
Career Highlights
Throughout his career, Kevin M. Elias has been affiliated with several prestigious institutions, most notably Dana-Farber Cancer Institute and Brigham and Women's Hospital. His work in these establishments reflects his commitment to advancing cancer research and improving patient outcomes. Elias has demonstrated an exceptional ability to bridge the gap between innovative research and practical applications in clinical settings.
Collaborations
Elias has collaborated with esteemed colleagues such as Dipanjan Chowdhury and Wojciech Fendler, enhancing the depth and breadth of his research initiatives. These collaborations have fostered an environment of innovation, leading to advancements that could potentially change the landscape of ovarian cancer detection and treatment.
Conclusion
Kevin M. Elias stands as a prominent figure in the realm of medical inventions, particularly concerning ovarian cancer. His innovative patents and collaborations with other experts highlight his dedication to improving healthcare through scientific discovery. As he continues to advance research in this critical area, Elias remains an influential inventor whose work has the potential to save lives and enhance the quality of life for many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile